Patients who've already had coronary artery bypass graft surgery showed a significant mortality benefit with Medtronic's CoreValve replacement heart valve than with open heart surgery, according to a clinical trial.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uGeAtC
Thanks for sharing good information.
ResponEliminaBovine Pericardium Tissue
TMVR Contract Manufacturing